BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20194572)

  • 21. Cytokines in schizophrenia and the effects of antipsychotic drugs.
    Drzyzga L; Obuchowicz E; Marcinowska A; Herman ZS
    Brain Behav Immun; 2006 Nov; 20(6):532-45. PubMed ID: 16580814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From Bedside to Bench: the Role of Anti-Tumor Necrosis Factor Agents in the Management of Immune-Mediated Inflammatory Diseases.
    Haraoui B; Russell AS; Keystone EC
    J Rheumatol Suppl; 2010 May; 85():1. PubMed ID: 20436160
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence for activation of immune system in heart failure: is there a role for anti-inflammatory therapy?
    Celis R; Torre-Martinez G; Torre-Amione G
    Curr Opin Cardiol; 2008 May; 23(3):254-60. PubMed ID: 18382215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is schizophrenia an autoimmune disease? A review.
    Knight JG
    Methods Find Exp Clin Pharmacol; 1984 Jul; 6(7):395-403. PubMed ID: 6390022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of epigenetics in altered gene expression involved in GABAergic transmission in the cerebellum of schizophrenia patients.
    Peedicayil J
    Am J Psychiatry; 2009 Apr; 166(4):493; author reply 493-4. PubMed ID: 19339371
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-inflammatory therapy in the neonatal intensive care unit: present and future.
    Watterberg K
    Semin Fetal Neonatal Med; 2006 Oct; 11(5):378-84. PubMed ID: 16632414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Women, schizophrenia and oestrogen; neurobiological hypotheses and hormonetherapy studies].
    Boerma MA; van der Stel JC; van Amelsvoort T; Linszen DH; de Haan L
    Tijdschr Psychiatr; 2010; 52(4):235-44. PubMed ID: 20503164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor Necrosis Factor and the consequences of its ablation in vivo.
    Efimov GA; Kruglov AA; Tillib SV; Kuprash DV; Nedospasov SA
    Mol Immunol; 2009 Nov; 47(1):19-27. PubMed ID: 19230974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding the 'central dogma': the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia.
    Perkins DO; Jeffries C; Sullivan P
    Mol Psychiatry; 2005 Jan; 10(1):69-78. PubMed ID: 15381925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-inflammatory drugs and atherosclerosis.
    Moubayed SP; Heinonen TM; Tardif JC
    Curr Opin Lipidol; 2007 Dec; 18(6):638-44. PubMed ID: 17993809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor and anti-tumor necrosis factor therapies.
    Keystone EC; Ware CF
    J Rheumatol Suppl; 2010 May; 85():27-39. PubMed ID: 20436163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidental neurodevelopmental episodes in the etiology of schizophrenia: an expanded model involving epigenetics and development.
    Singh SM; McDonald P; Murphy B; O'Reilly R
    Clin Genet; 2004 Jun; 65(6):435-40. PubMed ID: 15151498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a role for immune and anti-in-flammatory therapy in type 2 diabetes?
    Sathyapalan T; Atkin SL
    Minerva Endocrinol; 2011 Jun; 36(2):147-56. PubMed ID: 21519323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psoriasis--a systemic inflammatory disorder: clinic, pathogenesis and therapeutic perspectives.
    Boehncke WH; Sterry W
    J Dtsch Dermatol Ges; 2009 Nov; 7(11):946-52. PubMed ID: 19341429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroinflammation and the prospects for anti-inflammatory treatment of Parkinson's disease.
    Whitton PS
    Curr Opin Investig Drugs; 2010 Jul; 11(7):788-94. PubMed ID: 20571974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of schizophrenia in the 21st Century: beyond the neurotransmitter hypothesis.
    Rogers DP; Goldsmith CA
    Expert Rev Neurother; 2009 Jan; 9(1):47-54. PubMed ID: 19102668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study.
    Bower JH; Maraganore DM; Peterson BJ; Ahlskog JE; Rocca WA
    Neurology; 2006 Aug; 67(3):494-6. PubMed ID: 16894114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation in epithelial skin tumours: old stories and new ideas.
    Mueller MM
    Eur J Cancer; 2006 Apr; 42(6):735-44. PubMed ID: 16527478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines.
    Nawa H; Takei N
    Neurosci Res; 2006 Sep; 56(1):2-13. PubMed ID: 16837094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.